Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416649 · ClinicalTrials.gov registry record
Impact of Exenatide on Sleep Duration
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 8
- Enrollment target
NCT01416649 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 8 participants.
The verdict
NCT01416649 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
This study investigates the effect of exenatide, a FDA approved medication for the treatment of type 2 diabetes on sleep duration and quality. Individuals with type 2 diabetes will be studied before and during treatment with Exenatide. Enrolled individuals will be asked to come to the University of Chicago for 3-4 outpatient visits over the course of 3-4 months.
Interventions
- DRUG Exenatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-02-01 |
| Est. Completion | 2021-04-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01416649
The ClinicalTrials.gov registry entry for NCT01416649 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exenatide is the first listed.
NCT01416649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01416649 about?
NCT01416649 is a clinical study titled "Impact of Exenatide on Sleep Duration". This study investigates the effect of exenatide, a FDA approved medication for the treatment of type 2 diabetes on sleep duration and quality. Individuals with type 2 diabetes will be studied before and during treatment with Exenatide. Enrolled individuals will be asked to come to the University of...
What is the current status of trial NCT01416649?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2011-02-01. Estimated completion is 2021-04-21.
What interventions are being tested in trial NCT01416649?
The interventions under investigation include: Exenatide (DRUG).
Who is sponsoring clinical trial NCT01416649?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.